Abstrakt: |
Keywords: Antineoplastics; BCL-2 Inhibitors; Breast Cancer; Cancer; Drugs and Therapies; Health and Medicine; Oncology; Pharmaceuticals; Venetoclax Therapy; Women's Health EN Antineoplastics BCL-2 Inhibitors Breast Cancer Cancer Drugs and Therapies Health and Medicine Oncology Pharmaceuticals Venetoclax Therapy Women's Health 181 181 1 08/28/23 20230829 NES 230829 2023 AUG 29 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Investigators publish new report on breast cancer. Overall, FRV-1 is a novel Complex I inhibitor in D-active conformation, blocking possibly the re-activation to A-state, producing selective anti-cancer effects in NQO1-negative BC cell lines.". [Extracted from the article] |